Catalyst Wire Dossier Catalyst Wire Dossier

Levetiracetam intravenous infusion

levetiracetam · UCB Pharma SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levetiracetam intravenous infusion, covering 2011-02-25 to 2011-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy [Phase 2]

See pricing